DrugMar 22, 2017
Synergy Rx VI PEEL recall — FDA D-0578-2017
Lack of Assurance of Sterility: There are also CGMP Deviations.
Class IIFDA: TerminatedSynergy Rx
March 2017 recalls — page 6
These records include useful source details for the selected month.
DrugMar 22, 2017
PreviDent 5000 ppm, DRY MOUTH, 1.1% Sodium Fluoride, PRESCRIPTION STRENGTH TOOTHPASTE, SLS recall — FDA D-0521-2017
Label Mix up; rear panel is incorrectly labeled with the PreviDent 5000 Enamel Protect rear panel.
Class IIIFDA: TerminatedColgate Palmolive Co
DrugMar 22, 2017
Synergy Rx 5-FLUOROURACIL IN VANICREAM, FLUOROURACIL in all strengths including 0.05%, 5% recall — FDA D-0527-2017
Lack of Assurance of Sterility: There are also CGMP Deviations.
Class IIFDA: TerminatedSynergy Rx
DrugMar 22, 2017
Synergy Rx DICLOFENAC 3% and 5% LIP BALM and DICLOFENAC 5% SPF 30 LIP BALM recall — FDA D-0580-2017
Lack of Assurance of Sterility: There are also CGMP Deviations.
Class IIFDA: TerminatedSynergy Rx
DrugMar 22, 2017
Synergy Rx QUAD PEEL recall — FDA D-0568-2017
Lack of Assurance of Sterility: There are also CGMP Deviations.
Class IIFDA: TerminatedSynergy Rx
DrugMar 22, 2017
Synergy Rx QUAD BLEACHING CREAM recall — FDA D-0567-2017
Lack of Assurance of Sterility: There are also CGMP Deviations.
Class IIFDA: TerminatedSynergy Rx
DrugMar 22, 2017
Synergy Rx GENERIC VI PEEL recall — FDA D-0558-2017
Lack of Assurance of Sterility: There are also CGMP Deviations.
Class IIFDA: TerminatedSynergy Rx
DrugMar 22, 2017
Synergy Rx SUPREME BLEACHING CREAM recall — FDA D-0571-2017
Lack of Assurance of Sterility: There are also CGMP Deviations.
Class IIFDA: TerminatedSynergy Rx
DrugMar 22, 2017
Synergy Rx TRETINOIN CREAM in all strengths including: 0.1%, 0.05%, TRETINOIN GEL in all recall — FDA D-0588-2017
Lack of Assurance of Sterility: There are also CGMP Deviations.
Class IIFDA: TerminatedSynergy Rx
DrugMar 22, 2017
Synergy Rx FIRM AND FADE recall — FDA D-0557-2017
Lack of Assurance of Sterility: There are also CGMP Deviations.
Class IIFDA: TerminatedSynergy Rx
DrugMar 22, 2017
Synergy Rx HCG and HCG with resveratrol Human Chorionic Gonadotropin in different strengths recall — FDA D-0524-2017
Lack of Assurance of Sterility: There are also CGMP Deviations.
Class IIFDA: TerminatedSynergy Rx
DrugMar 22, 2017
Synergy Rx TRICHLOROACETIC ACID SOLUTION in all strengths including: 10%, 12%, 15 %, 20% recall — FDA D-0544-2017
Lack of Assurance of Sterility: There are also CGMP Deviations.
Class IIFDA: TerminatedSynergy Rx
DrugMar 22, 2017
Amerisource Health Services GlipiZIDE Extended-release tablets, 2.5 mg, 30-count carton recall — FDA D-0520-2017
Failed dissolution specifications: Glipizide 2.5 mg ER Tablets exceeded dissolution specification rates for the 10 hour testing point.
Class IIFDA: TerminatedAmerisource Health Services
DrugMar 22, 2017
Synergy Rx MALEK'S MAGIC recall — FDA D-0563-2017
Lack of Assurance of Sterility: There are also CGMP Deviations.
Class IIFDA: TerminatedSynergy Rx
DrugMar 22, 2017
Pharmedium Services Buffered Lidocaine, 1%, In Sodium Bicarbonate 8.4%, 1 mL Total Volume in recall — FDA D-0603-2017
Labeling; Label Mixup; outer packaging is incorrectly labeled as Buffered Lidocaine 1% instead of correctly as Buffered Lidocaine 0.9%
Class IIIFDA: TerminatedPharmedium Services, LLC
DrugMar 22, 2017
Synergy Rx DUO Cream recall — FDA D-0556-2017
Lack of Assurance of Sterility: There are also CGMP Deviations.
Class IIFDA: TerminatedSynergy Rx
DrugMar 22, 2017
PROTONIX I.V. (pantoprazole sodium) for Injection, Equivalent to 40 mg pantoprazole per recall — FDA D-0516-2017
Subpotent Drug: Out of Specification (OOS) for potency at the 6-month stability time point.
Class IIIFDA: TerminatedPfizer Inc.
DrugMar 22, 2017
Synergy Rx ENHANCED RETIN ANTI-WRINKLE CREAM, ENHANCED RETIN ANTI-WRINKLE CREAM 0.1% recall — FDA D-0583-2017
Lack of Assurance of Sterility: There are also CGMP Deviations.
Class IIFDA: TerminatedSynergy Rx
DrugMar 22, 2017
Synergy Rx HCG in all strength including: 2,400, 9600,12,000 UNIT POWDER VIAL DROPS, HCG recall — FDA D-0584-2017
Lack of Assurance of Sterility: There are also CGMP Deviations.
Class IIFDA: TerminatedSynergy Rx
DrugMar 22, 2017
Synergy Rx HYDROQUINONE CREAM in all strengths including 4%, 5%,6%, 7%, 8%, HYDROQUINONE recall — FDA D-0547-2017
Lack of Assurance of Sterility: There are also CGMP Deviations.
Class IIFDA: TerminatedSynergy Rx
DrugMar 22, 2017
Synergy Rx CLARIFYING CREAM recall — FDA D-0553-2017
Lack of Assurance of Sterility: There are also CGMP Deviations.
Class IIFDA: TerminatedSynergy Rx
DrugMar 22, 2017
Synergy Rx CLOBETASOL 0.05% IN OLEA BASE, CLOBETASOL 0.05% IN OROBASE, CLOBETASOL 0.05% recall — FDA D-0535-2017
Lack of Assurance of Sterility: There are also CGMP Deviations.
Class IIFDA: TerminatedSynergy Rx
DrugMar 22, 2017
G & W Laboratories Clindamycin Phosphate Topical Solution USP, 1% recall — FDA D-0519-2017
CGMP Deviations: an expired active ingredient was used in the manufacture of these recalled lots.
Class IIIFDA: TerminatedG & W Laboratories, Inc.
FoodMar 15, 2017
Trader Joes Company 10.5oz recall — FDA F-1584-2017
Trader Joe's Co. is recalling the Lemon Curd because it contains undeclared milk in the sub-ingredient of butter.
Class IIFDA: TerminatedTrader Joes Company
How to use this monthly recall archive
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.